Literature DB >> 8122615

Thrombolytic therapy in infants and children.

S S Kothari1, S Varma, H S Wasir.   

Abstract

Thrombolytic therapy is being increasingly used to treat various cardiac and other disorders in the pediatric population. The use of thrombolytic therapy in thrombosis following cardiac catheterization, aortic thrombosis, right atrial and caval thrombosis, pulmonary embolism, thrombosed prosthetic valves, thrombosed Blalock-Taussig shunts, and other disorders is delineated. Special issues of the newborn are discussed. A wider appreciation of the indications and contemporary experience would help in optimizing the use of thrombolytic therapy in children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8122615     DOI: 10.1016/0002-8703(94)90676-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Hemiconvulsion, hemiplegia, epilepsy syndrome and inherited protein S deficiency.

Authors:  R K Mondal; D Chakravorty; S Das
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

Review 3.  Pulmonary embolism in parenteral nutrition.

Authors:  C M Dollery
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

Review 4.  Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature.

Authors:  J Hartmann; A Hussein; E Trowitzsch; J Becker; K H Hennecke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

5.  Psychomotor delay, a possible rare presentation of moyamoya disease.

Authors:  M R Ashrafi; H Alizadeh; S H Yazdani; M Mohseni; M Mohamadi
Journal:  Iran J Radiol       Date:  2011-09-25       Impact factor: 0.212

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.